| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
3,878 |
3,573 |
$2.70M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
1,195 |
1,090 |
$1.57M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
505 |
433 |
$989K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,557 |
1,469 |
$667K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
2,503 |
928 |
$514K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,472 |
1,336 |
$274K |
| 80053 |
Comprehensive metabolic panel |
4,997 |
4,619 |
$224K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
2,322 |
2,149 |
$194K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
4,962 |
4,504 |
$187K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
1,282 |
544 |
$175K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
638 |
592 |
$148K |
| 71045 |
Radiologic examination, chest; single view |
496 |
448 |
$139K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,936 |
1,847 |
$138K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
927 |
857 |
$116K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,237 |
944 |
$82K |
| 80061 |
Lipid panel |
1,330 |
1,285 |
$77K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
693 |
638 |
$64K |
| 36415 |
Collection of venous blood by venipuncture |
4,615 |
4,259 |
$64K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
797 |
751 |
$57K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
770 |
688 |
$47K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
518 |
358 |
$46K |
| 71046 |
Radiologic examination, chest; 2 views |
119 |
112 |
$45K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,478 |
1,225 |
$42K |
| 97035 |
|
407 |
166 |
$42K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
784 |
564 |
$41K |
| 83690 |
|
1,082 |
994 |
$40K |
| 83605 |
|
354 |
327 |
$40K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
922 |
883 |
$35K |
| 70450 |
Computed tomography, head or brain; without contrast material |
27 |
26 |
$34K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
329 |
300 |
$31K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
284 |
122 |
$31K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
972 |
891 |
$28K |
| 82728 |
|
494 |
483 |
$25K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
148 |
141 |
$25K |
| 84703 |
|
638 |
590 |
$24K |
| 84484 |
|
524 |
437 |
$24K |
| 87400 |
|
385 |
192 |
$20K |
| 90836 |
|
880 |
599 |
$19K |
| 84439 |
|
450 |
430 |
$16K |
| 84481 |
|
259 |
239 |
$16K |
| 81001 |
|
1,277 |
1,175 |
$15K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
1,900 |
1,756 |
$15K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
168 |
156 |
$15K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
120 |
111 |
$15K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
155 |
116 |
$9K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
67 |
65 |
$9K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
67 |
65 |
$9K |
| 90834 |
Psychotherapy, 45 minutes with patient |
356 |
206 |
$8K |
| 81003 |
|
605 |
575 |
$8K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
229 |
212 |
$7K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
25 |
24 |
$7K |
| 83550 |
|
208 |
207 |
$7K |
| 36592 |
|
79 |
75 |
$6K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
27 |
13 |
$6K |
| 83540 |
|
207 |
206 |
$5K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
509 |
393 |
$5K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
817 |
720 |
$4K |
| 82607 |
|
53 |
53 |
$3K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
15 |
14 |
$3K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
442 |
399 |
$3K |
| 83880 |
|
15 |
15 |
$3K |
| 80306 |
|
33 |
31 |
$3K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
27 |
27 |
$2K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
71 |
69 |
$2K |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
908 |
620 |
$2K |
| 82550 |
|
33 |
29 |
$2K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
13 |
12 |
$1K |
| 80305 |
|
40 |
39 |
$1K |
| 97014 |
|
30 |
12 |
$1K |
| J3490 |
Unclassified drugs |
282 |
229 |
$1K |
| 84403 |
|
14 |
13 |
$1K |
| 90833 |
Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) |
89 |
70 |
$1K |
| 87807 |
|
15 |
15 |
$1K |
| 80320 |
|
118 |
108 |
$1K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
12 |
12 |
$902.46 |
| 86803 |
|
13 |
12 |
$884.90 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
12 |
12 |
$867.76 |
| 82553 |
|
15 |
14 |
$772.30 |
| 86140 |
|
40 |
39 |
$755.36 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
24 |
24 |
$720.14 |
| 86769 |
|
18 |
16 |
$640.74 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
201 |
192 |
$489.50 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
33 |
25 |
$68.26 |
| 90688 |
|
12 |
12 |
$33.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
14 |
14 |
$28.43 |
| Q2037 |
Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin) |
13 |
12 |
$0.00 |